What Are Exceptional Responders?
When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.
Exceptional responders of new drugs in clinical trials.
Predicting the Future of Cancer Surgery
Peter Scardino, Chair of MSK’s Department of Surgery, gives his views on what lies ahead for the surgical treatment of cancer.
Peter Scardino, Chair of MSK’s Department of Surgery and a specialist in the treatment of prostate cancers.